Aspects of the creation of neuroprotective antiinflammatory drugs

TitleAspects of the creation of neuroprotective antiinflammatory drugs
Publication TypeJournal Article
Year of Publication2019
AuthorsChekman, IS, Belenichev, IF, Syrovaja, AO, Gorchakova, NA, Buhtijarova, NV, Ryzhenko, VP, Levashova, OL, Chalenko, NN
Abbreviated Key TitleDopov. Nac. akad. nauk Ukr.
DOI10.15407/dopovidi2019.09.088
Issue9
SectionBiochemistry
Pagination88-98
Date Published09/2019
LanguageRussian
Abstract

The chemical, physiological, and pharmacological aspects of creation of neuroprotective antiinflammatory drugs are considered. It is stated the expediency of the creation of neuroprotective compounds among the 1,2,4- tri azol derivatives and antiinflammatory compounds as the coxibes derivatives. During the synthesis of new compounds, computer programs, quantum-chemical investigations, and virtual screening have been used to determine antioxidant properties.

Keywordsantiinflammatory antioxidant properties, computer programs, neuroprotective, quantum- chemical investigations, virtual screening
References: 

1. Belenichev, I. F., Cherniy, V. I., Nagorna, E. A., Pavlov, S. V. & Buhtiyarova, N. V. (2014). Neuroprotection and neuroplasticity. Kyiv: Logos (in Russian).
2. Aleksandrova, K., Belenichev, I., Shkoda, A., Levich, S., Yurchenko, D. & Buchtiyarova, N. (2014). Research of antioxidant properties of theophyllinyl-7-acetic acid derivatives. Oxid. Antioxid. Med. Sci., 3, No. 3, pp. 187-194. doi: https://doi.org/10.5455/oams.191214.or.078
3. Ryzhov, O. A., Ryzhenko, V.P., Levich, S. V. & Belenichev, I. F. (2017). Analysis of influence of quantum chemical descriptors on NO-scavenger properties among xanthine derivatives. Biological Markers and Guided Therapy, 4 No. 1, pp. 39-48. doi: https://doi.org/10.12988/bmgt.2017.735
4. Chekman, I. S., Kazakova, O. O. & Nebesna, T. Iu. (2008). Quantum-chemical and topological descriptors in studies of dependence “structure-activity” (review of literature and own research). Zhurn. Nac. akad. med. nauk Ukrainy, 14, No. 4, pp. 636-650 (in Ukrainian).
5. Foye, W. O. (2008). Foye’s principles of medicinal chemistry. 6th ed. Philadelphia: Lippincott Williams & Wilkins.
6. Chekman, I. S., Syrova, H. O., Kazakova, O. O., Horchakova, N. O., Belenichev, I. F., Zahorodnyi, M. I. Levashova, O. L., Chalenko, N. M., Pogotova, G. A., Dovgan, R. S. & Nagorna, O. O. (2017). Quantum chemistry: medical and pharmaceutical aspect. Kharkiv: Planeta-prynt (in Ukrainian).
7. Chekman, I. S., Syrovaya, A. O. & Levashova, O. L. (2018). Quantum-chemical aspects of non-steroidal antiinflamatory drugs. Kyiv, Kharkiv: Planeta-print.
8. Belenychev, Y. F., Nesterova, N. O., Kovalenko, S. I. & Karpenko, O.V. (2004). Formation of the combinato rial library of quinazolin-4-yl hydrazone with antioxidant activity. Med. Khimiia, 6, No. 3, pp. 14-21 (in Uk rainian).
9. Nebesna, T. Iu., Zahorodnyi, M. I., Yahupova, A. S., Horchakova, N. O. & Chekman, I. S. (2007). Study of the molecular structure and the quantum-chemical properties of acetyl cysteine. Ukr. nauk.-med. mol. zhurn., 1, No. 2, pp. 19-23 (in Ukrainian).
10. Chekman, I. S., Belenichev, I. F., Demchenko, A. V., Bobrova, V. I., Kucherenko, L. I., Gorchakova, N. A. & Bukhtiyarova, N. V. (2014). Nootropics in comlex therapy of chronic cerebral ischemia. Sci. Innov., 10 No. 4, pp. 56-68. doi: https://doi.org/10.15407/scine10.04.056
11. Ishihara, M., Wakabayashi, H., Motohashi, N. & Sakagami, H. (2010). Estimation of relationship between the structure of trihaloacetylazulene derivatives determined by a semiempirical molecular-orbital method (PM5) and their cytotoxicity. Anticancer Res., 30, No. 3, pp. 837-842.
12. Deniz, M., Borman, H., Seyhan, T. & Haberal, M. (2013). An effective antioxidant drug on prevention of the necrosis of zone of stasis: N-acetylcysteine. Burns, 39, No. 2, pp. 320-325. doi: https://doi.org/10.1016/j.burns.2012.06.015
13. Ryzhenko, V. P., Ryzhov, O. A., Belenichev, I. F. & Levich, S. V. (2018). Study of dependence of xanthine derivatives NO-scavenger properties from energy descriptors. Biological Markers and Guided Therapy, 15, No. 1, pp. 37-42. doi: https://doi.org/10.12988/bmgt.2018.857
14. Ryizhenko, V. P., Ryizhov, A. A., Levich, S. V., Belenichev, I. F. & Aleksandrova, E. V. (2016). Targeted search of substances among a number of 3-aryl(aralkyl)xantine derivatives having antiradical activity with regard to superoxide radicals. Med. Informatika ta Inzheneriya, 1, pp. 109 (in Russian).
15. Belenichev, I. F., Aleksandrova, K. V., Nosach, S. F., Levich, S. V., Yurchenko, D. M., Abramov, A. V. & Suprun, E. V. (2014). New xanthine derivative B-YR-2 as antioxidant modulator of post-stroke damage of sensorimotor cortex neurons in rats. Elixir Pharmacy, 76, pp. 28286-28292.